Advertisement

Interaction of MTHFR gene with smoking and alcohol use and haplotype combination susceptibility to psoriasis in Chinese population

  • Quan Luo
  • Jingxin Zeng
  • Wei Li
  • Ling Lin
  • Xin Zhou
  • Xin Tian
  • Weiyu Liu
  • Lidan Zhang
  • Xibao Zhang
Original Article
  • 21 Downloads

Abstract

To investigate the association of MTHFR gene polymorphism and additional gene–gene interaction with psoriasis risk. GMDR model was used to screen the best gene–smoking and gene–drinking interaction combinations. Logistic regression was performed to investigate association between two SNPs and psoriasis. For psoriasis patient-control haplotype analyses, the SHEsis online haplotype analysis software (http://analysis.bio-x.cn) was employed. We found that carriers of homozygous mutant of rs1801133 polymorphism and heterozygous of rs1801131 are associated with increased psoriasis risk than those with wild-type homozygotes, OR (95%CI) were 2.01 (1.48–2.79), and 2.08 (1.56–2.86), respectively. We also found a significant gene–environment interaction between C677T and alcohol drinking. In all samples, the haplotype 1298A-677C was observed most frequently in two groups, with 49.43 and 55.71% for the patients and controls, respectively. The results also indicated that the haplotype containing 1298C and 677T alleles were associated with a statistically increased psoriasis risk, OR (95%CI) = 1.73 (1.12–2.46), P = 0.0002. Our study found that rs1801133, rs1801131 within MTHFR gene, and interaction between C677T and alcohol drinking and haplotype containing the 1298C and 677T alleles were all associated with increased psoriasis risk.

Keywords

Psoriasis MTHFR SNP Interaction Haplotype 

Notes

Acknowledgements

The writing of this paper was supported by the Guangzhou Institute of Dermatology. We thank all the partners and staffs who help us in the process of this study.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70:512–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Krueger JG, Krane JF, Carter DM, Gottlieb AB. Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J Invest Dermatol. 1990;94:135S–40S.CrossRefPubMedGoogle Scholar
  3. 3.
    Zenz R, Eferl R, Kenner L, Florin L, Hummerich L, Mehic D, et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature. 2005;437:369–75.CrossRefPubMedGoogle Scholar
  4. 4.
    Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC. Dermatology. 2nd edition. Berlin: Springer-Verlag; 2000. p. 585–607.CrossRefGoogle Scholar
  5. 5.
    Qi JH, Qi JH, Shi N, Chen YJ, Nie G. Association between MTHFR 677C/T polymorphism and psoriasis risk: a meta-analysis. Genet Mol Res. 2015;14(2):3869–76.CrossRefPubMedGoogle Scholar
  6. 6.
    Bozduman T, Ersoy Evans S, Karahan S, Hayran Y, Akbiyik F, Lay I. Genetic risk factors for psoriasis in Turkish population: −1540 C/A, −1512 Ins18, and +405 C/G polymorphisms within the vascular endothelial growth factor gene. Ann Dermatol. 2016;28(1):30–9.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Białecka M, Ostasz R, Kurzawski M, Klimowicz A, Fabiańczyk H, Bojko P, et al. IL17A and IL17F gene polymorphism association with psoriasis risk and response to treatment in a polish population. Dermatology. 2016;232(5):592–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Wang H, Wang J, Zhao L, Liu X, Mi W. Methylenetetrahydrofolatereductase polymorphisms and risk of acute lymphoblastic leukemia-evidence from an updated meta-analysis including 35 studies. BMC Med Genet. 2012;13:77.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    van der Put NM, Gabreëls F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, et al. A second commonmutation in the methylenetetrahydrofolatereductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet. 1998;62:1044–51.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kilic S, Ozdemir O, Silan F, Isik S, Yildiz O, Karaagacli D, et al. Possible association between germlinemethylenetetrahydrofolatereductase gene polymorphisms and psoriasis risk in a Turkish population. ClinExpDermatol. 2017;42(1):8–13.Google Scholar
  11. 11.
    Wu D, Shi D, Yang L, Zhu X. Association between methylenetetrahydrofolatereductaseC677T polymorphism and psoriasis: a meta-analysis. J Dermatol. 2016;43(2):162–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology. 2005;210:194–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Xia X, Duan Y, Cui J, Jiang J, Lin L, Peng X, et al. Association of methylenetetrahydrofolatereductase gene-gene interaction and haplotype with susceptibility to acute lymphoblastic leukemia in Chinese children. Leuk Lymphoma. 2017;58(8):1887–92.CrossRefPubMedGoogle Scholar
  14. 14.
    Weger W, Hofer A, Stanger O, Wolf P, El-Shabrawi Y, Renner W, et al. The methylenetetrahydrofolatereductase 677C>T gene polymorphism is not associated with chronic plaque psoriasis. Exp Dermatol. 2008;17:748–51.CrossRefPubMedGoogle Scholar
  15. 15.
    Liew SC, Das-Gupta E, Wong SF, Lee N, Safdar N, Jamil A. Association of methylentetraydrofolatereductase (MTHFR) 677 C > T gene polymorphism and homocysteine levels in psoriasis vulgaris patients from Malaysia: a case-control study. Nutr J. 2012;11:1.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Karabacak E, Aydin E, Ozcan O, Dogan B, Gultepe M, Cosar A, et al. Methylenetetrahydrofolatereductase (MTHFR) 677C>T gene polymorphism as a possible factor for reducing clinical severity of psoriasis. Int J Clin Exp Med. 2014;7:697–702.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Stern LL, Mason JB, Selhub J, Choi SW. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolatereductase gene. Cancer Epidemiol Biomark Prev. 2000;9:849e53.Google Scholar
  18. 18.
    Baiqiu W, Songbin F, Guiyin Z, Pu L. Study of the relationship between psoriasis and the polymorphic site C677T of methylenetetrahydrofolatereductase. Chin Med Sci J. 2000;15:119e20.Google Scholar
  19. 19.
    Vasku V, Bienertova-Vasku J, Necas M, Vasku A. MTHFR (methylenetetrahydrofolatereductase) C677T polymorphism and psoriasis. Clin Exp Med. 2009;9:327–31.CrossRefPubMedGoogle Scholar
  20. 20.
    Izmirli M, Sen BB, Rifaioglu E, Gogebakan B, Aldemir O, Sen T, et al. Methylenetetrahydrofolatereductase (MTHFR) C677T polymorphism in psoriasis in southern Turkey. An Bras Dermatol. 2016;91(5):611–3.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Richer V, Roubille C, Fleming P, Starnino T, McCourt C, McFarlane A, et al. Psoriasis and smoking: a systematic literature review and meta-analysis with qualitative analysis of effect of smoking on psoriasis severity. J Cutan Med Surg. 2016;20(3):221–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Lønnberg AS, Skov L, Skytthe A, Kyvik KO, Pedersen OB, Thomsen SF. Smoking and risk for psoriasis: a population-based twin study. Int J Dermatol. 2016;55(2):e72–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Kwatra SG. Alcohol intake and risk of psoriasis: smoking as a confounding factor. Arch Dermatol. 2011;147(3):358.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Quan Luo
    • 1
  • Jingxin Zeng
    • 1
  • Wei Li
    • 1
  • Ling Lin
    • 1
  • Xin Zhou
    • 1
  • Xin Tian
    • 1
  • Weiyu Liu
    • 1
  • Lidan Zhang
    • 1
  • Xibao Zhang
    • 1
  1. 1.Department of DermatologyGuangzhou Institute of DermatologyGuangzhouChina

Personalised recommendations